Register for free to listen to this article
Listen with Speechify
0:00
1:00
BioTek Instruments Inc.
 
BioTek Instruments Inc. has expanded its Synergy Multi-ModeMicroplate Reader family with the introduction of the patent-pending Synergy H4with Hybrid Technology. Synergy H4 combines the sensitivity of filter-basedoptics with the flexibility of monochromator-based optics in one compactinstrument for high-performance fluorescence-based applications. This hybrid ofboth technologies provides for endless flexibility in current and futuremicroplate-based assay choice. Additionally, Synergy H4 is compatible withBioTek's Take3 Multi-Volume Plate for low-volume measurements down to 2 μL.Filter/dichroic-based fluorescence optics provide superior light filtering andpurification with fast wavelength switching and read speeds. This exceptionalperformance is perfect for demanding applications including TR-FRET,fluorescence polarization or AlphaScreen/AlphaLISA. Quadruplemonochromator-based fluorescence optics provide the flexibility to choose anywavelength from the UV to the near infrared for a broad range of applications.The variable bandpass selection system is ideal for spectral scanningapplications. Top and bottom optics enhance assay flexibility even further.Synergy H4 is modular, and the fully equipped configuration may be used forfluorescence intensity/FRET, time-resolved fluorescence (TRF) and TR-FRET,fluorescence polarization, AlphaScreen/AlphaLISA, Luminescence and UV-VisibleAbsorbance.
 
BioTek Instruments Inc.

(888) 451-5171
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Clear cells with round, blue centers are shown against a varied blue background

Supercharging cell line development and engineering with automated single cell sorting

Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue